Skip to main content
BALAXI PHARMACEUTICALS LIMITED logo

BALAXI PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · BALAXI ISIN · INE618N01022 LEI · 894500VRENAYIIWHHQ13 National Stock Exchange of India Wholesale and retail trade
Filings indexed 615 across all filing types
Latest filing 2025-08-06 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India BALAXI

About BALAXI PHARMACEUTICALS LIMITED

https://www.balaxipharma.in/

Balaxi Pharmaceuticals Limited is a specialty pharmaceutical company that operates an asset-light business model focused on sourcing, branding, and distributing generic formulations in frontier markets. The company primarily serves emerging economies across Africa and Latin America, including Angola, Guatemala, and the Dominican Republic. Its product portfolio encompasses a wide range of therapeutic segments such as anti-infectives, analgesics, and antimalarials. Balaxi manages an integrated supply chain, leveraging its regulatory expertise to register and market high-quality pharmaceutical products. By maintaining a robust distribution network and localized presence, the company ensures the availability of essential medicines in underserved regions while optimizing operational efficiency through its specialized procurement and logistics framework.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited consolidated and standalone financial results for the quarter ended June 30, 2025, including revenue, net profit, earnings per share, and other financial metrics. It references Regulation 33 and 52 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertain to quarterly financial results disclosures. The document is approximately 15,000 characters long and includes substantive financial data and analysis for the quarter, not merely an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-08-06 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 93% confidence The document is a notice to the stock exchange reporting the outcome of a board meeting held August 5, 2025, which approved the standalone and consolidated unaudited financial results for the quarter ended June 30, 2025. It includes full financial tables, notes, and indicates these results were reviewed by the audit committee and auditors. This matches the definition of an Interim/Quarterly Report (IR) – a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements. Q1 2026
2025-08-05 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 89% confidence The document is titled “Outcome of Board Meeting” filed with the stock exchange and contains the full unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, along with line‐by‐line financial statements and limited review statement. It is not merely a brief press highlights (ER) nor just an announcement linking to a separate report (RPA/RNS). It provides substantive quarterly financial data, meeting the definition of an Interim/Quarterly Report (IR). Q1 2026
2025-08-05 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings
2025-08-05 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is a letter filed to the stock exchange under SEBI Regulations announcing the outcome of a board meeting and enclosing the standalone and consolidated unaudited financial results for the quarter ended June 30, 2025. It contains full quarter-end financial statements (income, expenses, profit, EPS, notes) rather than a brief earnings highlight. Therefore it fits the definition of an Interim/Quarterly Report (IR), which covers substantive financial data for a period shorter than a full fiscal year. Q1 2026
2025-08-05 English
Copy of Newspaper Publication
Regulatory Filings Classification · 75% confidence The document is a stock‐exchange submission under SEBI LODR Regulations 30 and 47 disclosing the publication of a newspaper advertisement for the notice of the 82nd Annual General Meeting and remote e-voting. It does not contain financial statements, audit opinions, or detailed AGM materials—rather, it is a routine regulatory announcement of an event/notice. This best fits the general Regulatory Filings (RNS) category.
2025-08-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.